WNT10A is a member of the Wnt family of secreted signaling proteins, which are key morphogens regulating cell fate, proliferation, migration, and polarity during embryonic development and tissue homeostasis. The Wnt signaling pathway is evolutionarily conserved and plays essential roles in development, stem cell biology, and tissue regeneration. WNT10A, located on chromosome 2q35, is particularly important for epithelial-mesenchymal interactions during embryonic development and for maintaining adult tissue stem cell populations[1][2].
Mutations in WNT10A cause a spectrum of congenital disorders known as Wntopathies, primarily affecting ectodermal derivatives including hair, teeth, nails, and skin. These disorders include ectodermal dysplasia type 9, Schöpf-Schulz-Passarge syndrome, and related conditions with autosomal recessive inheritance[3][4]. In addition to its well-established developmental roles, recent research has revealed important functions for WNT10A in neurodevelopment and neurodegeneration, making it relevant to understanding brain disorders including Alzheimer's and Parkinson's diseases[5][6].
| Property | Value |
|---|---|
| Gene Symbol | WNT10A |
| Full Name | Wnt Family Member 10A |
| Chromosomal Location | 2q35 |
| NCBI Gene ID | 25480 |
| OMIM ID | 606228 |
| Ensembl ID | ENSG00000135925 |
| UniProt ID | Q9GZT5 |
| Encoded Protein | Wnt-10a protein |
| Protein Family | Wnt family of signaling proteins |
| Associated Diseases | Ectodermal dysplasia, Wntopathies, Alzheimer's disease, Parkinson's disease |
WNT10A is a secreted glycoprotein of approximately 421 amino acids with a molecular weight of about 46 kDa. The protein contains several distinctive structural features:
Signal peptide: The N-terminal signal peptide directs WNT10A to the secretory pathway, enabling its secretion from producing cells.
Wnt domain: The central region contains the conserved Wnt domain, characterized by:
Lipid modification site: Like other Wnt proteins, WNT10A undergoes palmitoylation at a conserved cysteine residue, which is essential for its secretion and function. This modification is catalyzed by the enzyme Porcupine (PORCN).
Receptor binding regions: Surface regions that interact with Wnt receptors (Frizzled proteins) and co-receptors (LRP5/6).
Wnt protein secretion requires a specialized machinery:
Wntless (WLS): The WLS protein is essential for Wnt secretion. WNT10A binds to WLS in the endoplasmic reticulum, is transported through the secretory pathway, and is released at the plasma membrane[7].
Porcupine-mediated acylation: The PORCN enzyme adds palmitoyl groups to WNT10A, enabling its association with lipid rafts and proper receptor interaction.
Extracellular transport: WNT10A can act in an autocrine or paracrine manner, diffusing through the extracellular matrix to reach target cells.
Gradient formation: WNT10A forms concentration gradients in tissues, with different concentrations specifying different cell fates during development.
WNT10A can activate the canonical Wnt pathway, which is the most well-characterized Wnt signaling cascade[1:1][2:1]:
Receptor binding: WNT10A binds to Frizzled (FZD) receptors, which are seven-pass transmembrane proteins, along with LRP5/6 co-receptors.
Dishevelled activation: Receptor activation leads to recruitment and activation of Dishevelled (DVL) proteins, which become phosphorylated and cluster at the membrane.
β-catenin stabilization: Activated DVL inhibits the β-catenin destruction complex (containing GSK3β, APC, Axin), preventing β-catenin phosphorylation and degradation.
Nuclear translocation: Stabilized β-catenin accumulates in the cytoplasm and translocates to the nucleus.
Target gene activation: In the nucleus, β-catenin interacts with TCF/LEF transcription factors to activate expression of target genes, including:
WNT10A also signals through non-canonical pathways that do not involve β-catenin[8]:
Planar Cell Polarity (PCP) pathway:
Wnt/Ca2+ pathway:
Rho GTPase regulation:
WNT10A plays critical roles in embryonic development[9]:
Limb development:
Hair follicle formation:
Tooth development:
Skin appendage formation:
WNT10A is important for maintaining stem cell populations[10]:
Epithelial stem cells:
Neural stem cells:
Mesenchymal stem cells:
Cancer stem cells:
WNT10A has important functions in nervous system development[11][12]:
Neural tube patterning:
Neuronal differentiation:
Axon guidance:
Synapse formation:
WNT10A plays roles in synaptic function and plasticity[13]:
Synapse formation:
Synaptic plasticity:
Presynaptic function:
WNT10A and Wnt signaling more broadly are implicated in Alzheimer's disease pathogenesis[14][6:1][15][16]:
Amyloid-beta effects on Wnt signaling:
Tau pathology interaction:
Synaptic dysfunction:
Neuroinflammation:
Therapeutic potential:
WNT10A and Wnt pathway dysregulation are also implicated in PD[@L'Episcopo2019]:
Dopaminergic neuron development:
α-Synuclein pathology:
Mitochondrial function:
Neuroinflammation:
Therapeutic targeting:
Amyotrophic Lateral Sclerosis (ALS):
Multiple Sclerosis:
Brain aging:
WNT10A shows specific expression patterns:
In the nervous system:
Developmental expression:
Adult expression:
Cellular localization:
Modulating Wnt signaling has therapeutic potential[17]:
Wnt agonists:
Wnt antagonists:
GSK3β inhibitors:
Porcupine inhibitors:
Potential therapeutic uses include:
Regenerative medicine:
Neurodegenerative disease:
Cancer therapy:
| Receptor | Pathway | Function |
|---|---|---|
| Frizzled (FZD1-10) | Canonical/Non-canonical | Primary Wnt receptors |
| LRP5/6 | Canonical | Co-receptors for β-catenin pathway |
| ROR1/2 | Non-canonical | Alternative receptors |
| Ryk | Non-canonical | Axon guidance receptor |
Positive regulators:
Negative regulators:
Clevers H, et al. Wnt/beta-catenin signaling and disease. Cell. 2007. ↩︎ ↩︎
MacDonald BT, et al. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009. ↩︎ ↩︎
Adaimy L, et al. WNT10A mutation in an Dominican family with autosomal dominant hypodontia. Am J Hum Genet. 2012. ↩︎
Niemann S, et al. WNT10A mutations cause a spectrum of ectodermal dysplasias. J Med Genet. 2014. ↩︎
Liu Y, et al. Wnt signaling in neurodegeneration. Adv Exp Med Biol. 2015. ↩︎
Inestrosa NC, et al. Wnt signaling in Alzheimer's disease: nice to have or needed?. Adv Exp Med Biol. 2013. ↩︎ ↩︎
Bänfgi D, et al. Wntless in Wnt secretion and disease. Small GTPases. 2018. ↩︎
Kimmel AR, et al. Regulation of Wnt signaling by CK2. Mol Cell. 2000. ↩︎
Wong YC, et al. Wnt signaling in hair follicle development and cycling. Birth Defects Res C Embryo Today. 2012. ↩︎
Reya T, et al. Stem cells, cancer, and cancer stem cells. Nature. 2005. ↩︎
Barolo S, et al. Wnt signaling in neural development. Front Cell Neurosci. 2012. ↩︎
Shimogawa TK, et al. Wnt signaling and neural circuit formation. Dev Neurobiol. 2014. ↩︎
Cerpa W, et al. Wnt signaling in synaptic plasticity and disease. Adv Exp Med Biol. 2015. ↩︎
Inestrosa NC, et al. Wnt signaling in brain: role in development and neurodegeneration. Neurochem Int. 2012. ↩︎
Zhang Z, et al. Wnt/beta-catenin in Alzheimer's disease. Neurochem Int. 2015. ↩︎
Palomer E, et al. Wnt signaling dysregulation in Alzheimer's disease. Front Aging Neurosci. 2019. ↩︎
Kahn M, et al. Can we safely target the Wnt pathway?. Nat Rev Drug Discov. 2014. ↩︎